Chloramphenicol: Screening and review to evaluate its potential beneficial effects in leukaemia

Journal of the Indian Medical Association

Volumn 105, Issue 4, 2007, Pages 224-228

  Lokhande, J ^a   Juvekar, A S ^a,b   Kulkarni, K P ^a  

^a Alkem Laboratories Limited   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

Anticancer drugs; Cancer cell lines; Chloramphenicol; Leukaemia

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CHLORAMPHENICOL; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; IDARUBICIN; MITOXANTRONE; VINCRISTINE; ANTIINFECTIVE AGENT; PROTEIN SYNTHESIS INHIBITOR;

APLASTIC ANEMIA; ARTICLE; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CYTOPENIA; DRUG EFFECT; DRUG SCREENING; FEBRILE NEUTROPENIA; HUMAN; HUMAN CELL; LEUKEMIA; IN VITRO STUDY;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CHLORAMPHENICOL; HUMANS; LEUKEMIA; PROTEIN SYNTHESIS INHIBITORS;

EID: 35248890496     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bhutani M, Kochupillai V, Bakshi S - Childhood acute lymphoblastic leukemia : Indian experience. Indian J Med Paediatr Oncol 2004; 25: 3-8.
2. Chandy M - Childhood acute lymphoblastic leukemia in India: an approach to management in a three- tier society. Med Pediatr Oncol 1995; 25: 197-203.
3. Ferkin F, Chesterman C, Penington D, Ruch B, editors - De Gruchy's Clinical Haematology in Medical Practice. 5th ed. Oxford: Oxford University Press, 1989: 236-77.
4. Chambers HF - Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's The Principal of Pharmacological Basis of Therapeutics, 11th ed. New York: McGraw-Hill, 2006: 1179-82.
5. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al - New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-12.
6. Greene MH, Boice JD Jr, Greer BE, Blessing JA, Dembo AJ - Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. N Engl J Med 1982; 307: 1416-21.
7. Greene MH, Harris EL, Gershenson DM, Malkasian GD Jr, Melton LJ 3d, Denbo AJ, et al - Melphalan may be a more potent leukemogen than cyclophosphamide. Ann Intern Med 1986; 105: 360-7.
8. Neglia JP Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB, et al - Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325: 1330-6.
9. Kollmannsberger C, Hartmann JT, Kanz L, Bokemeyer C - Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies. J Cancer Res Clin Oncol 1998; 124: 207-14.
10. Tucker MA, Meadows AT, Boice JD Jr, Stovall M, Oberlin O, Stone BJ, et al - Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 1987; 78: 459-64.
11. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA - Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988; 318: 76-81.
12. Jerzy RK, Joanna N, Jerzy A - Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a Polish pediatric leukemia/lymphoma group Med Sci Monit 2004; 10: CR117-22.
13. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP - Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 324: 808-15.
14. Adamson RH, Seiber SM - Chemically induced leukemia in humans. Environ Health Perspect 1981; 39: 93-103.
15. Doona M, Walsh JB - Use of chloramphenicol as topical eye medication: time to cry halt? BMJ 1995; 310: 1217-8.
16. Klein B, Bessler H, Lewinski UH, Cohen AM, Djaldetti M - Beneficial effect of chloramphenicol on pyrexia in patients with acute leukemia. Acta Haematol 1980; 64: 246-50.
17. Bostrom B, Smith K, Ramsay NK - Low-dose chloramphenicol stimulates granulocyte/monocyte colony-forming units. N Engl J Med 1984; 310: 723-4.
18. Scott JL, Finegold SM, Belkin GA, et al - A controlled double-blind study of the hematologic toxicity of chloramphenicol. N Engl J Med 1965; 272: 1137-42.